NEWS
FDA-cleared personalized brain therapy achieves 68 percent remission for PTSDA newly FDA-cleared treatment for PTSD (MeRT) reported a 68 percent remission rate in the maker's own clinical trial. Medications sit around 10.9 percent remission in a separate review — a cross-study comparison, not a head-to-head result. This is a news summary compiled for the İyi Giden Şeyler newsletter — not the original article. The original article is at optimistdaily.com. Read the original article English (automatic translation) |